Neurocrine Biosciences, Inc. (NASDAQ:NBIX) Posted Basic Consolidated EPS Of $-1.0525

0

Neurocrine Biosciences, Inc. (NASDAQ:NBIX) annual basic consolidated EPS was $-1.0525 for the period ended 2015-12-31. The basic consolidated EPS was $-1.0525 for the quarter ended 2015-12-31.

EPS from continuing operations

Neurocrine Biosciences, Inc. (NASDAQ:NBIX)’s basic EPS from continuing operations was $-1.0525 for the fiscal year 2015-12-31. For the quarter ended 2015-12-31 it stood at $-1.0525

EPS contribution from parent

From the parent company Neurocrine Biosciences, Inc. (NASDAQ:NBIX) posted basic EPS of $-1.0525 for the fiscal ended 2015-12-31. For the quarter that ended on 2015-12-31 the figure stood at $-1.0525.

Basic net EPS

The Basic net EPS of Neurocrine Biosciences, Inc. (NASDAQ:NBIX) was $-1.05 for the period ended 2015-12-31. The figure stood at $-1.05 for the quarter that ended 2015-12-31.

Consolidated diluted EPS

The consolidated diluted EPS for the fiscal year 2015-12-31 stood at $-1.0525. While the figure for the quarter ended 2015-12-31 stood at $-1.0525.

Basic diluted EPS

The diluted EPS from continuing operation of Neurocrine Biosciences, Inc. (NASDAQ:NBIX) stood at $-1.0525 for the fiscal 2015-12-31. The figure for the quarter ended 2015-12-31 stood at $-1.0525

Net diluted EPS

The Net diluted EPS was $-1.05 for the fiscal 2015-12-31. The figure for the quarter ended 2015-12-31 stood at $-1.05.

Diluted EPS from parent

Neurocrine Biosciences, Inc. (NASDAQ:NBIX) diluted EPS from the parent company for the fiscal 2015-12-31 was $-1.0525. The figure for the quarter ended 2015-12-31 was $-1.0525

The net basic EPS was $-1.05 for fiscal 2015-12-31. The figure for the quarter ended 2015-12-31 was $-1.05

1 Chart Pattern Every Investor Should Know

This little-known pattern preceded moves of 578% in ARWR, 562% in LCI, 513% in ICPT, 439% in EGRX, 408% in ADDUS and more...

Click Here to See This Now.

(Visited 8 times, 1 visits today)